Beitzke A, Mache C J, Stein J I, Suppan C
Department für Kardiologie, Universitäts-Kinderklinik, Graz.
Wien Klin Wochenschr. 1991;103(3):75-81.
Two series of 1,000 consecutive cardiac catheterizations in neonates, infants and older children were prospectively investigated with respect to catheter-induced complications. These were categorized into arrhythmias, vascular complications, catheter and contrast perforations, central nervous (CNS) complications, clinical deterioration and catheter-related death. Comparing series 1 and 2, the number of arrhythmias decreased from 7.6% to 5.0%, acute vascular complications decreased from 2.1% to 1.4%, the number of patients showing clinical deterioration from 2.6% to 0.6% and CNS complications from 0.4% to 0.1%, whereas catheter or contrast perforations-remained virtually constant at 0.4% and 0.5% respectively. Catheter-induced mortality decreased from 2.0% to 0.7%. The group of neonates showed the greatest reduction in serious complications and catheter-induced mortality (31.3% to 12.4% and 11.0% to 4.4%, respectively). Increasing experience of the investigators, introduction of two-dimensional echocardiography as a supplementary investigation or even catheter substitute, use of percutaneous catheterization and sheath techniques, introduction of E-type prostaglandins and increased use of intubation and anaesthesia for catheterization all played an important role in the improvement shown in this investigation. Complications are still mainly seen in the group of neonates and cyanotic patients.
对两组各1000例新生儿、婴儿及大龄儿童连续进行心脏导管插入术,并对导管相关并发症进行前瞻性研究。这些并发症分为心律失常、血管并发症、导管及造影剂穿孔、中枢神经(CNS)并发症、临床病情恶化及导管相关死亡。比较第1组和第2组,心律失常的发生率从7.6%降至5.0%,急性血管并发症从2.1%降至1.4%,临床病情恶化的患者数量从2.6%降至0.6%,CNS并发症从0.4%降至0.1%,而导管或造影剂穿孔分别维持在0.4%和0.5%基本不变。导管相关死亡率从2.0%降至0.7%。新生儿组严重并发症和导管相关死亡率降低幅度最大(分别从31.3%降至12.4%和从11.0%降至4.4%)。研究人员经验的增加、引入二维超声心动图作为辅助检查甚至导管替代手段、使用经皮导管插入术和鞘管技术、引入E型前列腺素以及增加导管插入术时插管和麻醉的使用,在本研究显示的改善中均发挥了重要作用。并发症仍主要见于新生儿组和发绀患者。